Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Psychopharmacology (Berl). 2014 Apr 30;231(21):4231–4240. doi: 10.1007/s00213-014-3566-6

Table 2.

Volumes (mm3) of the Regions of Interest by Diagnostic Group

ROI Controls (n=21) SPD Participants (n=18) pa
PFC:
 DLPFC 25037 ± 5708 20116 ± 5531 0.010
 MPFC 5546 ± 2290 4204 ± 2059 0.064
 OFC 11821 ± 5356 10709 ± 4104 0.477

Striatal:
 VST 1638 ± 428 1600 ± 427 0.781
 preDCA 4598 ± 749 4245 ± 704 0.140
 preDPU 3831 ± 591 3781 ± 535 0.785
 postCA 997 ± 301 846 ± 266 0.109
 postPU 4102 ± 689 3911 ± 512 0.337

Note. Mean ± Standard Deviation.

DLPFC=dorsolateral prefrontal cortex; MPFC=medial prefrontal cortex; OFC=orbitofrontal cortex; PFC=prefrontal cortex; postCA=postcommissural caudate; postPU=postcommissural putamen; preDCA=precommissural dorsal caudate; preDPU=precommissural dorsal putamen; ROI=region of interest; SPD=schizotypal personality disorder; VST=ventral striatum.

a

Independent-samples t-test.

HHS Vulnerability Disclosure